Traders Buy CME Group (CME) on Weakness

Investors bought shares of CME Group Inc (NASDAQ:CME) on weakness during trading hours on Monday. $80.06 million flowed into the stock on the tick-up and $59.35 million flowed out of the stock on the tick-down, for a money net flow of $20.71 million into the stock. Of all stocks tracked, CME Group had the 28th highest net in-flow for the day. CME Group traded down ($2.73) for the day and closed at $162.38

A number of research firms have commented on CME. Barclays raised their target price on shares of CME Group from $170.00 to $175.00 and gave the stock an “overweight” rating in a research note on Friday, February 2nd. Bank of America lifted their price objective on shares of CME Group from $173.00 to $175.00 and gave the company a “buy” rating in a research report on Friday, February 2nd. Sandler O’Neill reiterated a “buy” rating and set a $175.00 price objective on shares of CME Group in a research report on Friday, February 2nd. Goldman Sachs Group upgraded shares of CME Group from a “neutral” rating to a “buy” rating and set a $180.00 price objective on the stock in a research report on Wednesday, February 7th. Finally, BidaskClub upgraded shares of CME Group from a “buy” rating to a “strong-buy” rating in a research report on Saturday, February 10th. Three equities research analysts have rated the stock with a hold rating, eleven have assigned a buy rating and one has issued a strong buy rating to the stock. CME Group currently has a consensus rating of “Buy” and an average price target of $157.00.

The stock has a market cap of $55,260.00, a PE ratio of 37.07, a price-to-earnings-growth ratio of 2.10 and a beta of 0.64. The company has a quick ratio of 1.05, a current ratio of 1.03 and a debt-to-equity ratio of 0.10.

CME Group (NASDAQ:CME) last announced its quarterly earnings results on Thursday, February 1st. The financial services provider reported $1.12 earnings per share for the quarter, topping the consensus estimate of $1.10 by $0.02. CME Group had a net margin of 111.49% and a return on equity of 7.68%. The company had revenue of $900.00 million for the quarter, compared to analysts’ expectations of $886.85 million. During the same quarter in the previous year, the business posted $1.14 earnings per share. CME Group’s quarterly revenue was down 1.4% on a year-over-year basis. analysts expect that CME Group Inc will post 6.32 earnings per share for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Monday, March 26th. Investors of record on Friday, March 9th will be given a $0.70 dividend. This represents a $2.80 annualized dividend and a yield of 1.72%. The ex-dividend date is Thursday, March 8th. This is a boost from CME Group’s previous quarterly dividend of $0.66. CME Group’s payout ratio is currently 60.27%.

In related news, insider Derek Sammann sold 2,400 shares of the business’s stock in a transaction on Friday, February 2nd. The shares were sold at an average price of $161.66, for a total value of $387,984.00. Following the sale, the insider now owns 40,153 shares in the company, valued at $6,491,133.98. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO John W. Pietrowicz sold 7,500 shares of the business’s stock in a transaction on Tuesday, January 9th. The stock was sold at an average price of $151.50, for a total transaction of $1,136,250.00. Following the completion of the sale, the chief financial officer now owns 32,376 shares in the company, valued at approximately $4,904,964. The disclosure for this sale can be found here. Insiders sold 64,728 shares of company stock worth $9,755,257 in the last 90 days. 0.57% of the stock is currently owned by company insiders.

A number of hedge funds and other institutional investors have recently bought and sold shares of CME. Cetera Investment Advisers purchased a new position in CME Group during the second quarter worth $242,000. Shell Asset Management Co. boosted its stake in CME Group by 94.2% during the third quarter. Shell Asset Management Co. now owns 73,892 shares of the financial services provider’s stock worth $5,908,000 after buying an additional 35,842 shares during the period. Assenagon Asset Management S.A. boosted its stake in CME Group by 133.9% during the third quarter. Assenagon Asset Management S.A. now owns 75,199 shares of the financial services provider’s stock worth $10,203,000 after buying an additional 43,055 shares during the period. Sabal Trust CO purchased a new position in CME Group during the third quarter worth $15,494,000. Finally, Sumitomo Life Insurance Co. boosted its stake in CME Group by 19.9% during the third quarter. Sumitomo Life Insurance Co. now owns 23,140 shares of the financial services provider’s stock worth $3,140,000 after buying an additional 3,842 shares during the period. 82.63% of the stock is owned by institutional investors.

TRADEMARK VIOLATION WARNING: This story was posted by The Lincolnian Online and is the sole property of of The Lincolnian Online. If you are viewing this story on another site, it was illegally copied and reposted in violation of international copyright laws. The original version of this story can be viewed at https://www.thelincolnianonline.com/2018/02/19/traders-buy-cme-group-cme-on-weakness.html.

About CME Group

CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply